Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two new …
R Kumar, V Verma, A Sarswat, JP Maikhuri… - Investigational new …, 2012 - Springer
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new …
R Kumar, V Verma, A Sarswat… - Investigational …, 2012 - pubmed.ncbi.nlm.nih.gov
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
[引用][C] Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two …
R Kumar, V Verma, A Sarswat, JP Maikhuri… - Investigational New …, 2010 - cir.nii.ac.jp
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic
hyperplasia by multiple beneficial mechanisms—action of two new agents | CiNii Research …
hyperplasia by multiple beneficial mechanisms—action of two new agents | CiNii Research …
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two new …
R Kumar, V Verma, A Sarswat, JP Maikhuri… - Investigational New …, 2012 - infona.pl
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new …
R Kumar, V Verma, A Sarswat, JP Maikhuri… - Investigational New …, 2012 - hero.epa.gov
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new …
R Kumar, V Verma, A Sarswat, JP Maikhuri… - Investigational new …, 2010 - europepmc.org
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic
hyperplasia by multiple beneficial mechanisms--action of two new agents. - Abstract - Europe …
hyperplasia by multiple beneficial mechanisms--action of two new agents. - Abstract - Europe …
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new …
R Kumar, V Verma, A Sarswat… - Investigational New …, 2012 - search.proquest.com
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
undesirable side-effects; hence new agents acting by different mechanism (s) are required …
[PDF][PDF] Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two …
R Kumar, V Verma, A Sarswat, JP Maikhuri, A Jain… - 2010 - researchgate.net
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable sideeffects; hence new agents acting by different mechanism (s) are required as …
undesirable sideeffects; hence new agents acting by different mechanism (s) are required as …
[PDF][PDF] Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two …
R Kumar, V Verma, A Sarswat, JP Maikhuri, A Jain… - 2010 - academia.edu
The existing drugs for benign prostatic hyperplasia (BPH) are partially effective with
undesirable sideeffects; hence new agents acting by different mechanism (s) are required as …
undesirable sideeffects; hence new agents acting by different mechanism (s) are required as …